Global Biosensors Market Report 2022-2035: Biosensing Technologies in Drug Discovery Operations to Increase R&D Productivity – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Biosensors Market: Focus on Drug Discovery and Development – Distribution by Type of Biosensor, Type of End User and Key Geographies – Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering. At present, various types of biosensors, including optical biosensors, electrochemical biosensors, thermal biosensors and others, are being deployed … [Read more…]

Insights on the Oncology Information System Global Market to 2029 – by Application, Software, End-user and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Oncology Information System Market by Application (Medical, Radiation, Surgical Oncology), by Software (Patient Information System, TPS, RIS, PACS, Services), End User (Hospitals, Cancer Care Centers, Government Institution) and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global oncology information systems market size is estimated to be USD … [Read more…]

In Vitro Diagnostic Market Update, Q4, 2021: The Major Trends Affecting the Market – Telehealth and Remote Patient Monitoring, Multiplex and Syndromic Testing, Personalized Medicine, Point-of-Care – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostic Market Brief Update” report has been added to ResearchAndMarkets.com’s offering. What Major Trends are Affecting the Market Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from the analysts to reflect the latest information as of Q4 2021. … [Read more…]

Worldwide Colorectal Cancer Screening Tests Industry to 2029 – Introduction of Effective Genetic Tests is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Colorectal Cancer Screening Tests Market Analysis by Screening Test (Flexible Sigmoidoscopy, Stool-Based Tests, CT Colonography, Colonoscopy), by End User (Independent Diagnostic Labs, Hospitals), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global colorectal cancer screening tests market size is estimated to be USD 12,994 million in … [Read more…]

Novaremed Enters Into an Exclusive Option and License Agreement With NeuroFront for the Non-opioid Neuropathic Pain Treatment, NRD.E1, for Greater China and Singapore

NeuroFront receives an exclusive option for an exclusive license to develop, commercialize and manufacture NRD.E1, Novaremed’s first-in-class, non-opioid investigational drug for the treatment of chronic neuropathic pain in Greater China and Singapore Novaremed is entitled to receive a total of over USD 130 million in option and exercise fees as well as development, regulatory and … [Read more…]

DentalMonitoring: July Product Announcements

AUSTIN, Texas & PARIS–(BUSINESS WIRE)–DentalMonitoring has launched a breakthrough service for dental professionals and industry partners: the DM Intelligent Platform is now the only digital workflow which can interface and integrate with all dental digital solutions available on the market today. This industry-first accomplishment reinforces DentalMonitoring’s vision of making dentistry smarter, helping improve clinical outcomes … [Read more…]

Second Innate Pharma NK Cell Engager Selected by Sanofi as Drug Candidate for Development

IPH6401/SAR’514 is a BCMA-targeting NK cell engager using Sanofi’s proprietary CROSSODILE® multi-functional platform. It was developed jointly and benefits from the dual NK targeting of Innate’s ANKETTM proprietary platform Selection of IPH6401/SAR’514 triggers a €3M milestone payment to Innate MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) … [Read more…]

First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China

– Peking Union Medical College Hospital Primary Clinical Trial Site BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China and US-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that the first patient has been dosed in the CAN103 Phase 1/2 trial in … [Read more…]

Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs

BEIJING, China & TOKYO–(BUSINESS WIRE)–#CCR8–February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies using Biocytogen’s advanced antibody discovery platform based on fully human antibody RenMabTM mice combined with LiberoThera’s outstanding membrane antigen preparation technology. In around a year since the … [Read more…]

WHO Must Declare Monkeypox a Pandemic, say AHF, MPact and Mexican NGOs

LOS ANGELES–(BUSINESS WIRE)–#monkeypox–With the World Health Organization set to meet for the second time tomorrow to decide whether to declare monkeypox a Public Health Emergency of International Concern (PHEIC), AIDS Healthcare Foundation strongly urges the WHO to acknowledge the rapid, uncontrolled spread of the virus and declare it a pandemic. Monkeypox has spread to over … [Read more…]